Detalles de la búsqueda
1.
A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization - results from IQVIA™ Disease Analyzer Germany.
Eur J Clin Pharmacol
; 79(6): 849-858, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37095262
2.
Assessing heterogeneity of electronic health-care databases: A case study of background incidence rates of venous thromboembolism.
Pharmacoepidemiol Drug Saf
; 32(9): 1032-1048, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068170
3.
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
Pharmacoepidemiol Drug Saf
; 32(1): 44-55, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215113
4.
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice.
Br J Clin Pharmacol
; 88(10): 4526-4539, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35483963
5.
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.
Value Health
; 25(10): 1663-1672, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36241338
6.
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
Pharmacoepidemiol Drug Saf
; 30(3): 334-341, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33099846
7.
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data.
Pharmacoepidemiol Drug Saf
; 30(3): 350-359, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33197106
8.
Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.
Br J Clin Pharmacol
; 86(7): 1336-1345, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068906
9.
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.
Br J Clin Pharmacol
; 86(6): 1034-1051, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162368
10.
Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?
Pharmacoepidemiol Drug Saf
; 29(10): 1336-1340, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32301230
11.
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic.
Pharmacoepidemiol Drug Saf
; 29(8): 825-831, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369865
12.
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study.
Eur J Clin Pharmacol
; 75(7): 979-984, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30838424
13.
Prescribing patterns of tramadol in adults in IMS® primary care databases in France and Germany between 1 January 2006 and 30 June 2016.
Eur J Clin Pharmacol
; 75(5): 707-716, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675632
14.
The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies.
Pharmacoepidemiol Drug Saf
; 28(4): 422-433, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30838708
15.
A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children.
Pharmacoepidemiol Drug Saf
; 28(8): 1086-1096, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31219227
16.
Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.
BMC Med
; 16(1): 6, 2018 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29332605
17.
Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.
Br J Clin Pharmacol
; 84(3): 419-433, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29105853
18.
Imposed registries within the European postmarketing surveillance system: Extended analysis and lessons learned for regulators.
Pharmacoepidemiol Drug Saf
; 27(7): 823-826, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29749086
19.
Application of real-time global media monitoring and 'derived questions' for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines.
BMC Med
; 15(1): 91, 2017 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28464900
20.
Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability.
Pharmacoepidemiol Drug Saf
; 31(12): 1308-1310, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35959980